中国阿尔茨海默病的成本及对全球成本的再估计。
The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
机构信息
Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China; Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China; Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, China; Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China; National Clinical Research Center for Geriatric Disorders, Beijing, China.
Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China.
出版信息
Alzheimers Dement. 2018 Apr;14(4):483-491. doi: 10.1016/j.jalz.2017.12.006. Epub 2018 Feb 9.
INTRODUCTION
The socioeconomic costs of Alzheimer's disease (AD) in China and its impact on global economic burden remain uncertain.
METHODS
We collected data from 3098 patients with AD in 81 representative centers across China and estimated AD costs for individual patient and total patients in China in 2015. Based on this data, we re-estimated the worldwide costs of AD.
RESULTS
The annual socioeconomic cost per patient was US $19,144.36, and total costs were US $167.74 billion in 2015. The annual total costs are predicted to reach US $507.49 billion in 2030 and US $1.89 trillion in 2050. Based on our results, the global estimates of costs for dementia were US $957.56 billion in 2015, and will be US $2.54 trillion in 2030, and US $9.12 trillion in 2050, much more than the predictions by the World Alzheimer Report 2015.
DISCUSSION
China bears a heavy burden of AD costs, which greatly change the estimates of AD cost worldwide.
简介
中国阿尔茨海默病（AD）的社会经济成本及其对全球经济负担的影响尚不确定。
方法
我们从中国 81 个有代表性的中心的 3098 名 AD 患者中收集数据，并估计了 2015 年中国每位患者和所有患者的 AD 成本。基于这些数据，我们重新估算了全球 AD 的成本。
结果
2015 年每位患者的年社会经济成本为 19144.36 美元，总费用为 1677.40 亿美元。预计到 2030 年，年总成本将达到 5074.90 亿美元，到 2050 年将达到 18900 亿美元。根据我们的结果，2015 年全球痴呆症成本估计为 9575.60 亿美元，到 2030 年将达到 25400 亿美元，到 2050 年将达到 91200 亿美元，远高于《2015 年世界阿尔茨海默病报告》的预测。
讨论
中国承担着沉重的 AD 成本负担，这极大地改变了全球 AD 成本的估计。
Zotero 插件